SNCA and Alzheimer disease: In some AD cases, specific neuronal populations are vulnerable to develop Lewy body pathology of α-synuclein [43,46], which is a signature of Parkinson’s disease (PD), mostly at the axonal level, in cortico-limbic regions, olfactory bulbs and substantia nigra.